Atlas Trials

The Study of Pharmacokinetics and Pharmacodynamics of Huperzine A Injection in Healthy Chinese Subjects

Clinical trial NCT06570655 · COMPLETED

Trial details

NCT number
NCT06570655
Sponsor
Wanbangde Pharmaceutical Group Co., LTD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2024-05-16
Primary completion
2024-06-20
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.